HighVista Strategies’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.85M	Buy	+49,050	New	+$2.26M	0.79%	42
2025 Q4	–	Sell	-82,190	Closed	-$3.3M	–	179
2025 Q3	$3.3M	Buy	82,190 +36,570	+80%	+$1.29M	0.81%	36
2025 Q2	$1.43M	Sell	45,620 -21,168	-32%	-$690K	0.52%	73
2025 Q1	$2.24M	Hold	66,788	–	–	0.86%	27
2024 Q4	$2.62M	Sell	66,788 -6,974	-9%	-$288K	0.97%	25
2024 Q3	$2.9M	Buy	73,762 +1,047	+1%	+$42.2K	1%	31
2024 Q2	$2.84M	Hold	72,715	–	–	1.04%	22
2024 Q1	$3.13M	Buy	72,715 +20,914	+40%	+$962K	1.12%	25
2023 Q4	$2.39M	Buy	51,801 +16,546	+47%	+$585K	0.87%	37
2023 Q3	$1.2M	Buy	35,255 +17,680	+101%	+$661K	0.56%	50
2023 Q2	$677K	Sell	17,575 -7,765	-31%	-$309K	0.31%	101
2023 Q1	$907K	Hold	25,340	–	–	0.74%	39
2022 Q4	$999K	Buy	25,340 +2,768	+12%	+$101K	0.59%	45
2022 Q3	$815K	Buy	22,572 +137	+0.6%	+$4.93K	0.47%	54
2022 Q2	$682K	Sell	22,435 -5,557	-20%	-$168K	0.41%	57
2022 Q1	$856K	Sell	27,992 -34,914	-56%	-$1.05M	0.54%	52
2021 Q4	$1.97M	Sell	62,906 -12,140	-16%	-$363K	1.56%	13
2021 Q3	$1.15M	Buy	75,046 +34,087	+83%	+$592K	0.76%	44
2021 Q2	$763K	Buy	+40,959	New	+$755K	0.54%	60
2020 Q4	–	Sell	-43,517	Closed	-$482K	–	133
2020 Q3	$482K	Buy	43,517 +23,278	+115%	+$274K	0.35%	54
2020 Q2	$254K	Buy	+20,239	New	+$258K	0.21%	70